Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial.

Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL, Hertel PM, Karpen SJ, Kerkar N, Molleston JP, Murray KF, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Suchy FJ, Turmelle YP, Wang KS, Sherker AH, Sokol RJ, Bezerra JA, Magee JC; ChiLDReN Network.

J Pediatr. 2018 Nov;202:179-185.e4. doi: 10.1016/j.jpeds.2018.07.002. Epub 2018 Sep 21.

PMID:
30244988
2.

Diagnostic Accuracy of Serum Matrix Metalloproteinase-7 for Biliary Atresia.

Yang L, Zhou Y, Xu PP, Mourya R, Lei HY, Cao GQ, Xiong XL, Xu H, Duan XF, Wang N, Fei L, Chang XP, Zhang X, Jiang M, Bezerra JA, Tang ST.

Hepatology. 2018 Dec;68(6):2069-2077. doi: 10.1002/hep.30234. Epub 2018 Nov 15.

PMID:
30153340
3.

Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.

Yang L, Mizuochi T, Shivakumar P, Mourya R, Luo Z, Gutta S, Bezerra JA.

J Hepatol. 2018 Nov;69(5):1136-1144. doi: 10.1016/j.jhep.2018.05.038. Epub 2018 Jun 8.

PMID:
29886157
4.

BILIARY ATRESIA: Clinical and Research Challenges for the 21st Century.

Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ.

Hepatology. 2018 Mar 31. doi: 10.1002/hep.29905. [Epub ahead of print]

PMID:
29604222
5.

Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study.

Ng VL, Sorensen LG, Alonso EM, Fredericks EM, Ye W, Moore J, Karpen SJ, Shneider BL, Molleston JP, Bezerra JA, Murray KF, Loomes KM, Rosenthal P, Squires RH, Wang K, Arnon R, Schwarz KB, Turmelle YP, Haber BH, Sherker AH, Magee JC, Sokol RJ; Childhood Liver Disease Research Network (ChiLDReN).

J Pediatr. 2018 May;196:139-147.e3. doi: 10.1016/j.jpeds.2017.12.048. Epub 2018 Mar 5.

PMID:
29519540
6.

Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia.

Lertudomphonwanit C, Mourya R, Fei L, Zhang Y, Gutta S, Yang L, Bove KE, Shivakumar P, Bezerra JA.

Sci Transl Med. 2017 Nov 22;9(417). pii: eaan8462. doi: 10.1126/scitranslmed.aan8462.

7.

Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Luo Z, Jegga AG, Bezerra JA.

Hepatology. 2017 Sep 2. doi: 10.1002/hep.29504. [Epub ahead of print]

PMID:
28865156
8.

Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia.

Jee J, Mourya R, Shivakumar P, Fei L, Wagner M, Bezerra JA.

PLoS One. 2017 Aug 1;12(8):e0182089. doi: 10.1371/journal.pone.0182089. eCollection 2017.

9.

Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?

Shneider BL, Moore J, Kerkar N, Magee JC, Ye W, Karpen SJ, Kamath BM, Molleston JP, Bezerra JA, Murray KF, Loomes KM, Whitington PF, Rosenthal P, Squires RH, Guthery SL, Arnon R, Schwarz KB, Turmelle YP, Sherker AH, Sokol RJ; Childhood Liver Disease Research Network.

PLoS One. 2017 May 11;12(5):e0176275. doi: 10.1371/journal.pone.0176275. eCollection 2017.

10.

Preferential TNFα signaling via TNFR2 regulates epithelial injury and duct obstruction in experimental biliary atresia.

Shivakumar P, Mizuochi T, Mourya R, Gutta S, Yang L, Luo Z, Bezerra JA.

JCI Insight. 2017 Mar 9;2(5):e88747. doi: 10.1172/jci.insight.88747.

11.

Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.

Asai A, Aihara E, Watson C, Mourya R, Mizuochi T, Shivakumar P, Phelan K, Mayhew C, Helmrath M, Takebe T, Wells J, Bezerra JA.

Development. 2017 Mar 15;144(6):1056-1064. doi: 10.1242/dev.142794.

12.

Biliary atresia and other cholestatic childhood diseases: Advances and future challenges.

Verkade HJ, Bezerra JA, Davenport M, Schreiber RA, Mieli-Vergani G, Hulscher JB, Sokol RJ, Kelly DA, Ure B, Whitington PF, Samyn M, Petersen C.

J Hepatol. 2016 Sep;65(3):631-42. doi: 10.1016/j.jhep.2016.04.032. Epub 2016 May 6. Review.

PMID:
27164551
13.

Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.

Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, Schwarz K, Whitington PF, Bezerra JA, Kerkar N, Haber B, Rosenthal P, Turmelle YP, Molleston JP, Murray KF, Ng VL, Wang KS, Romero R, Squires RH, Arnon R, Sherker AH, Moore J, Ye W, Sokol RJ; Childhood Liver Disease Research Network (ChiLDReN).

J Pediatr. 2016 Mar;170:211-7.e1-2. doi: 10.1016/j.jpeds.2015.11.058. Epub 2015 Dec 24.

14.

MDR3 mutation analysis: A step closer to precision medicine.

Bezerra JA.

Hepatology. 2016 May;63(5):1421-3. doi: 10.1002/hep.28408. Epub 2016 Feb 19. No abstract available.

15.

Increased frequency of double and triple heterozygous gene variants in children with intrahepatic cholestasis.

Goldschmidt ML, Mourya R, Connor J, Dexheimer P, Karns R, Miethke A, Sheridan R, Zhang K, Bezerra JA.

Hepatol Res. 2016 Apr;46(4):306-11. doi: 10.1111/hepr.12545. Epub 2015 Jul 14.

16.

Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Asai A, Miethke A, Bezerra JA.

Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):342-52. doi: 10.1038/nrgastro.2015.74. Epub 2015 May 26. Review.

17.

Natural killer cells promote long-term hepatobiliary inflammation in a low-dose rotavirus model of experimental biliary atresia.

Squires JE, Shivakumar P, Mourya R, Bessho K, Walters S, Bezerra JA.

PLoS One. 2015 May 19;10(5):e0127191. doi: 10.1371/journal.pone.0127191. eCollection 2015.

18.

Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia.

Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston J, Murray KF, Ng VL, Raghunathan T, Rosenthal P, Schwartz K, Sherker AH, Sokol RJ, Teckman J, Wang K, Whitington PF, Heubi JE; Childhood Liver Disease Research and Education Network.

J Pediatr Gastroenterol Nutr. 2014 Dec;59(6):702-7. doi: 10.1097/MPG.0000000000000547.

19.

Reply: To PMID 24493287.

Mourya R, Bessho K, Shivakumar P, Bezerra JA.

Hepatology. 2015 Feb;61(2):732-3. doi: 10.1002/hep.27231. Epub 2014 Jul 31. No abstract available.

PMID:
24844795
20.

Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial.

Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B, Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Murray KF, Romero R, Schwarz KB, Shepherd R, Suchy FJ, Turmelle YP, Whitington PF, Moore J, Sherker AH, Robuck PR, Sokol RJ; Childhood Liver Disease Research and Education Network (ChiLDREN).

JAMA. 2014 May 7;311(17):1750-9. doi: 10.1001/jama.2014.2623.

Supplemental Content

Loading ...
Support Center